🔬 Research Spotlight: MOTS-c & PCOS — What New Human Research Found

Could Mitochondrial Signaling Be Connected to PCOS?

A new 2026 human study is bringing attention to an interesting connection between MOTS-c, mitochondrial function, and polycystic ovary syndrome (PCOS).

Researchers discovered that women with PCOS had significantly lower levels of naturally occurring MOTS-c in both their blood and skeletal muscle compared with women without PCOS.

But what does that actually mean?

Let's break down the research in simple terms.

---

🧬 First — What Is MOTS-c?

MOTS-c is a small mitochondrial-derived peptide.

Mitochondria are commonly called the "powerhouses of the cell" because they help cells produce usable energy.

But mitochondria do much more than simply make energy.

They also participate in:

• Metabolism

• Glucose regulation

• Cellular signaling

• Responses to cellular stress

• Energy balance

MOTS-c is one of the signaling molecules being investigated for its involvement in these processes.

You can think of MOTS-c as one of the messages associated with the cell's energy system, helping coordinate how cells respond to metabolic demands.

---

🔎 Why Did Researchers Look at PCOS?

PCOS is a complex endocrine and metabolic condition.

Researchers have become increasingly interested in the role that mitochondrial function and metabolic signaling may play in PCOS.

Because MOTS-c has been associated with glucose regulation and skeletal-muscle metabolism, researchers wanted to answer an important question:

Do women with PCOS have different levels of MOTS-c than women without PCOS?

---

👩‍🔬 The Study

Researchers studied 80 women.

40 Women With PCOS

compared with

40 Women Without PCOS

The groups were matched for age and BMI, helping researchers make a more appropriate comparison between them.

Researchers then measured MOTS-c in two places:

🩸 Blood

Serum MOTS-c concentrations were measured in all 80 women.

💪 Skeletal Muscle

Researchers also examined MOTS-c expression directly within skeletal-muscle samples from a smaller subgroup.

This allowed researchers to look at MOTS-c both circulating in the body and within metabolically active tissue.

---

📊 What Did They Find?

This is where the results became particularly interesting.

MOTS-c Was Much Lower in the Blood

Average circulating MOTS-c levels were approximately:

Women Without PCOS

498 pg/mL

Women With PCOS

220 pg/mL

That means circulating MOTS-c was approximately 56% lower in the PCOS group.

---

💪 MOTS-c Was Also Lower in Skeletal Muscle

Researchers observed a similar pattern when they examined skeletal muscle.

MOTS-c expression was approximately:

Women Without PCOS

100 units

Women With PCOS

74 units

The researchers therefore weren't seeing a difference only in the bloodstream.

Reduced MOTS-c was also observed directly within skeletal muscle.

---

⚡ Why Is Skeletal Muscle Important?

Skeletal muscle isn't only responsible for movement.

It is also an extremely important metabolic tissue.

Skeletal muscle participates in:

• Glucose utilization

• Energy expenditure

• Insulin-related signaling

• Mitochondrial activity

• Overall metabolic regulation

Finding lower MOTS-c within skeletal muscle therefore gives researchers another clue that mitochondrial signaling may be altered in PCOS.

---

🧪 Researchers Found Another Interesting Connection

Lower circulating MOTS-c levels were also associated with:

⬆️ Higher Total Testosterone

and

⬆️ Higher Total Cholesterol

Both hormonal and metabolic abnormalities can occur in PCOS.

This raises an interesting research question:

Could altered mitochondrial signaling be connected with some of the endocrine and metabolic characteristics observed in PCOS?

At this point, researchers don't know the complete answer.

But these findings give scientists another pathway to investigate.

---

🔋 Think of It Like a Cellular Communication System

Here's one simple way to picture the research.

Imagine mitochondria as tiny power plants inside our cells.

Those power plants don't simply produce energy—they also communicate with the rest of the cell.

MOTS-c can be thought of as one of the signals associated with that mitochondrial communication system.

The study found:

PCOS

↓

Lower naturally occurring MOTS-c

↓

Less MOTS-c signaling detected in blood and skeletal muscle

↓

Possible connection with altered mitochondrial and metabolic function

Researchers are now trying to understand exactly what that relationship means.

---

🔬 Could MOTS-c Become a Biomarker?

Possibly.

A biomarker is something measurable that researchers can use as an indicator of a biological process or condition.

The researchers suggest that MOTS-c may potentially serve as a marker of tissue-specific mitochondrial involvement in PCOS.

That doesn't mean MOTS-c is currently a diagnostic test for PCOS.

Instead, it means researchers have identified something measurable that could help scientists better understand the mitochondrial component of PCOS in future studies.

---

⚠️ What This Study Does NOT Tell Us

This distinction is extremely important.

The researchers did NOT give participants MOTS-c.

They measured the MOTS-c that the women's bodies naturally produced.

Therefore, this study does NOT demonstrate that administering MOTS-c:

• Treats PCOS

• Improves PCOS symptoms

• Lowers testosterone

• Lowers cholesterol

• Improves fertility

• Corrects insulin resistance

The study identified an association.

It did not establish cause and effect.

---

🔗 Association ≠ Causation

Researchers found that PCOS and lower MOTS-c occurred together.

That doesn't yet tell us:

Does PCOS cause MOTS-c to decrease?

Does reduced MOTS-c contribute to PCOS?

Does mitochondrial dysfunction influence both?

Or are several biological mechanisms involved?

Those questions require additional research.

This is a perfect example of why association does not automatically equal causation.

---

⭐ The Big Takeaway

This 2026 human study found that women with PCOS had substantially lower naturally occurring MOTS-c in both their blood and skeletal muscle compared with women without PCOS.

Researchers also observed relationships between lower MOTS-c and higher testosterone and total cholesterol.

Together, the findings strengthen scientific interest in the possible connection between:

Mitochondria → MOTS-c signaling → Metabolism → Endocrine function → PCOS

MOTS-c may eventually help researchers better understand mitochondrial dysfunction associated with PCOS.

But this research is still developing.

One study gives us an important clue — not the final answer.

---

📚 Study Information

Study: Reduced serum and skeletal muscle MOTS-c levels in women with polycystic ovary syndrome are associated with mitochondrial dysfunction

Journal: Scientific Reports

Published: February 12, 2026

Participants: 80 women — 40 with PCOS and 40 age- and BMI-matched controls

PMID: 41680431

DOI: 10.1038/s41598-026-39687-x

Read the original study:
https://pubmed.ncbi.nlm.nih.gov/41680431/